Related references
Note: Only part of the references are listed.Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology
Jesse D. Le et al.
EUROPEAN UROLOGY (2015)
Addressing the need for repeat prostate biopsy: new technology and approaches
Michael L. Blute et al.
NATURE REVIEWS UROLOGY (2015)
The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation
Mahul B. Amin et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer
Siao-Yi Wang et al.
BJU INTERNATIONAL (2014)
Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer
Annelies Vellekoop et al.
JOURNAL OF UROLOGY (2014)
Management of low risk prostate cancer-active surveillance and focal therapy
Laurence Klotz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Development and Multi-Institutional Validation of an Upgrading Risk Tool for Gleason 6 Prostate Cancer
Matthew Truong et al.
CANCER (2013)
Biomarkers in prostate cancer surveillance and screening: past, present, and futureBiomarkers in prostate cancer surveillance and screening: past, present, and future
K. Clint Cary et al.
THERAPEUTIC ADVANCES IN UROLOGY (2013)
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2012)
Clinical and Demographic Characteristics Associated With Prostate Cancer Progression in Patients on Active Surveillance
Viacheslav Iremashvili et al.
JOURNAL OF UROLOGY (2012)
Active Surveillance for Prostate Cancer: Progress and Promise
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Jeffrey J. Tosoian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance
Sima P. Porten et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Relationship Between Prostate Specific Antigen Change and Biopsy Progression in Patients on Active Surveillance for Prostate Cancer
Jared M. Whitson et al.
JOURNAL OF UROLOGY (2011)
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener et al.
JOURNAL OF UROLOGY (2011)
Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program
Ashley E. Ross et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer
Simon L. Conti et al.
JOURNAL OF UROLOGY (2009)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
Share Paper
